News
Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
4d
Clinical Trials Arena on MSNFDA Commissioner envisions fewer delays, more clinical trial flexibility and AI useFDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.
4d
The Mirror US on MSNFDA to fast-track drug approvals for companies pushing ‘national priorities’ in major overhaulFood and Drug Administration Commissioner Marty Makary announced that the agency intends to fast-track reviews for certain ...
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to ...
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
In case you haven't had enough artificial intelligence, the US Food and Drug Administration is now outsourcing its oversight ...
2d
Pharmaceutical Technology on MSNFDA cell and gene therapy director exit increases ‘volatility’ for sectorNicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...
The Maryland Tech Council, the largest technology and life sciences trade association in the state, is pleased to announce that Dr. Marty Makary, Commissioner of the Food and Drug Administration, will ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results